Falls and other non-dopaminergic symptoms in Parkinson’s disease remain a significant unmet need, with limited effective ...
Multiple studies have shown the over-the-counter pill is effective ...
At AD/PD 2026, Roche announced that patients treated with prasinezumab for five years demonstrated a sustained slowing of ...
A daily aspirin could prevent bowel cancer or slow down its progression, a study claims. Scientists found that patients with ...
A phase 3 trial examines whether carfilzomib-lenalidomide-dexamethasone maintenance therapy improves disease control compared ...
The only typing clinicians may need to do in the future is to enter their login information.AI scribes have the capability to ...
(Nasdaq: RZLT) (“Rezolute” or the “Company”), a late-stage rare disease company focused on treating hypoglycemia caused by all forms of hyperinsulinism (HI), today announced outcomes from an in-person ...
Doctors in Liverpool working with researchers at the Center for Trials Research at Cardiff University have identified ...
Researchers at the Columbia University Fertility Center have designed and developed a novel technology that delivers ...
Pfizer and Valneva announce Lyme disease vaccine candidate demonstrates strong efficacy in phase 3 VALOR trial: New York Tuesday, March 24, 2026, 12:00 Hrs [IST] Pfizer Inc. and V ...
Morning Overview on MSN
Pfizer, Valneva Lyme vaccine misses primary endpoint despite efficacy
Pfizer and Valneva’s experimental Lyme disease vaccine, VLA15, failed to meet the primary endpoint of its late-stage clinical trial, even though the shot demonstrated more than 70% efficacy against ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results